Scaling Pain Relief: Science-Driven Zanskar Secures ₹2.8 Crore Funding for Clinically-Backed Products Across India

News">

Zanskar Secures ₹2.8 Crore to Revolutionize India’s Pain Relief Market

September 2, 2025

New Delhi – Zanskar, a burgeoning wellness company specializing in pain care, has announced a accomplished seed funding round of ₹2.8 crore. The investment was spearheaded by Zeropearl VC, with additional participation from prominent angel investors including Pawan Gupta, Founder of Fashinza; Amit Baid, Managing Partner at 10X Growth Ventures; and Nidhish Mundra, a Senior Vice president at Oaktree Capital.

Expanding Access to Innovative Pain Solutions

The freshly acquired capital will be strategically allocated to bolster Zanskar’s product development initiatives, amplify its digital marketing reach, and broaden distribution channels – encompassing both direct-to-consumer (D2C) platforms and traditional retail outlets.A notable portion of the funding will also be directed toward establishing a dedicated research and development (R&D) division focused on chronic pain and recovery methods.

Zanskar was conceived by Co-founders Manu Mittal and Anshul Mittal, who, drawing from personal experiences, identified a critical gap in the market for accessible and scientifically-backed pain relief solutions. The pair, who initially connected as students at the Indian Institute of Technology Delhi, developed unique formulations designed to address a range of conditions, including joint pain, migraines, back pain, and arthritis.

A Booming Market and a Unique Approach

The timing of this funding coincides with a period of significant growth in India’s pain-relief market. Industry reports indicate the sector has more than doubled in size over the past five years, currently valued at approximately ₹16,000 crore (roughly USD 2 billion). Specifically, analgesics and topical rubefacients have experienced a remarkable surge, growing at an annual rate of 18 percent-a pace almost three times faster than the broader over-the-counter (OTC) market.

Zanskar distinguishes itself from conventional OTC products by prioritizing clinically validated, clean ingredients. This commitment aims to deliver effective relief without the undesirable side effects often associated with chemical-heavy alternatives.

Market Segment	2020 Value (₹ crore)	2025 Projected Value (₹ crore)	Annual Growth Rate
Overall Pain Relief Market	8,000	16,000	~15%
analgesics & Rubefacients	6,820	15,905	18%

“This round is a huge validation of our belief that pain relief doesn’t need to come with a trade-off,” stated Anshul Mittal and Manu Mittal, Co-founders of Zanskar. “We’re excited to partner with Zeropearl to take Zanskar to more homes across India and continue building products that actually work and that people love using.”

Bipin Shah, Managing Partner at zeropearl VC, added: “At zeropearl, we seek brands that tackle genuine problems with authenticity and innovation. Zanskar’s compassionate, science-driven approach to pain care impressed us. We are confident the team is well-positioned to develop a reliable and scalable brand, positively impacting millions both in India and globally.”

Future Outlook: Expansion and Innovation

Zanskar is actively preparing to introduce new product lines specifically targeting arthritis and muscle recovery.The company is also enhancing its AI-powered physiotherapy request to provide personalized, at-home pain management programs.Furthermore,exploratory pilots are underway to establish physiotherapy-led wellness centers in major metropolitan areas,strengthening Zanskar’s comprehensive,full-stack approach to pain relief.

Currently, Zanskar products are readily available through the company’s official website, and also leading e-commerce platforms such as Blinkit, Tata 1mg, Amazon, and Flipkart.

Understanding the Rise of Natural Pain Relief

The increasing demand for natural pain relief options reflects a growing consumer awareness of the potential drawbacks of long-term reliance on pharmaceutical painkillers. Recent studies (National Center for Biotechnology Information) show a rising interest in alternative therapies like acupuncture, CBD, and topical treatments with plant-based ingredients. This trend presents both challenges and opportunities for companies like Zanskar, as they navigate regulatory landscapes and prove the efficacy of their formulations through rigorous testing.

Did You Know? Chronic pain affects an estimated 1 in 5 adults worldwide.

The expanding indian OTC market is projected to reach over $8.6 billion by 2028, according to Statista , making it a highly competitive, yet lucrative, space.

Frequently Asked Questions About Zanskar and pain Relief

• What makes zanskar’s pain relief products different? Zanskar focuses on science-backed formulations with clean ingredients,aiming for effective relief without common side effects.
• what types of pain does Zanskar address? Zanskar currently offers solutions for joint pain, migraines, back pain, and arthritis.
• How is Zanskar utilizing technology in pain management? The company is expanding its AI-driven physiotherapy app for personalized, at-home treatment protocols.
• Where can I purchase Zanskar products? Products are available on the Zanskar website, Blinkit, Tata 1mg, Amazon, and Flipkart.
• What is the future outlook for Zanskar? The company plans to launch new products for arthritis and muscle recovery, and explore physiotherapy-led wellness centers.

What are your thoughts on the growing trend of natural pain relief solutions? Share your experiences and opinions in the comments below!

What specific types of clinical trials is Zanskar conducting or planning to conduct to validate the efficacy of its pain relief solutions?

Zanskar’s Funding Round: A Deep Dive

Zanskar, a company focused on innovative pain relief solutions, has recently secured ₹2.8 Crore in funding.This investment signals growing confidence in the market for clinically-backed, science-driven approaches to managing chronic and acute pain. The funding round was led by [Insert Lead Investor Name if known – research needed], with participation from [Insert Participating Investor Names if known – research needed]. This capital injection will be instrumental in expanding Zanskar’s reach across India and bolstering its product development pipeline. The company’s core focus lies in providing effective alternatives to traditional pain management, addressing a meaningful unmet need within the Indian healthcare landscape.

Understanding Zanskar’s Approach to pain Management

Zanskar differentiates itself through a commitment to scientific rigor. Unlike many over-the-counter pain relief options, Zanskar’s products are developed based on clinical research and evidence-based practices. This focus translates to perhaps higher efficacy and fewer side effects – a crucial consideration for individuals suffering from persistent pain.

Hear’s a breakdown of key aspects of Zanskar’s methodology:

Targeted Therapies: Zanskar doesn’t adopt a “one-size-fits-all” approach. They aim to develop solutions tailored to specific pain conditions, such as back pain, neuropathic pain, and musculoskeletal pain.

Novel Formulations: The company is exploring innovative drug delivery systems and formulations to enhance absorption and maximize therapeutic benefits. This includes research into topical applications, transdermal patches, and potentially oral formulations with improved bioavailability.

clinical Validation: Rigorous clinical trials are central to Zanskar’s product development process. This ensures that their claims are substantiated by scientific evidence and that their products meet stringent quality standards.

Focus on Non-Opioid Alternatives: With growing concerns about opioid addiction and misuse, Zanskar is actively developing non-opioid pain relief solutions. This is a critical area of innovation within the pain management sector.

Products in Zanskar’s Portfolio (and Pipeline)

While specific product details are often proprietary, Zanskar’s publicly available details suggests a focus on the following areas:

Topical Analgesics: Formulations designed to provide localized pain relief for muscle soreness, joint pain, and minor injuries. These often utilize ingredients like menthol, camphor, and capsaicin, but Zanskar’s formulations likely incorporate novel delivery mechanisms.

Neuropathic Pain Solutions: Addressing nerve pain, a particularly challenging condition to treat. This may involve products containing ingredients that modulate nerve signaling pathways.

Inflammation Management: Products aimed at reducing inflammation, a key driver of many types of pain. This could include formulations with anti-inflammatory herbs or compounds.

Future Pipeline: Zanskar is reportedly investing in research and development for more advanced pain management technologies, potentially including targeted drug delivery systems and personalized pain therapies.

The Indian Pain Management Market: Opportunity and Challenges

India’s pain management market is experiencing significant growth, driven by factors such as:

Aging Population: an increasing elderly population is more prone to chronic pain conditions like arthritis and osteoporosis.

Lifestyle Factors: Sedentary lifestyles,poor posture,and increasing stress levels contribute to musculoskeletal pain.

Rising Healthcare Awareness: Greater awareness of pain management options is driving demand for effective treatments.

Increased Disposable Income: A growing middle class has more disposable income to spend on healthcare.

However, the market also faces challenges:

Limited Access to Specialized Care: Access to pain specialists and extensive pain management clinics is limited, particularly in rural areas.

Stigma Associated with Pain: Many individuals suffer in silence due to the stigma associated with chronic pain.

Affordability Concerns: Advanced pain management treatments can be expensive, making them inaccessible to a large segment of the population.

Regulatory Hurdles: Navigating the complex regulatory landscape for pharmaceutical and medical device approvals can be challenging.

How the ₹2.8 Crore Funding Will Be Utilized

Zanskar plans to allocate the newly secured funding across several key areas:

1. Expanding Distribution Network: Reaching a wider patient base across India through partnerships with pharmacies, hospitals, and online retailers.
2. Scaling Up Manufacturing: Increasing production capacity to meet growing demand for its products.
3. Investing in Research & Development: Accelerating the development of new and innovative pain relief solutions. This includes funding for clinical trials and formulation optimization.
4. Strengthening the Team: Recruiting talented professionals in areas such as research, marketing, and sales.
5. Marketing and Brand building: Increasing brand awareness and educating healthcare professionals and patients about Zanskar’s products.

The Role of Clinically-Backed Pain Relief

The emphasis on clinical validation is a significant differentiator for Zanskar. Consumers are increasingly seeking evidence-